Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19239 | 449 | 24.2 | 66% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 597 | 13382 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FIBROLAMELLAR HEPATOCELLULAR CARCINOMA | Author keyword | 39 | 73% | 7% | 30 |
| 2 | FIBROLAMELLAR CARCINOMA | Author keyword | 18 | 53% | 5% | 24 |
| 3 | COMBINED HEPATOCELLULAR AND CHOLANGIOCARCINOMA | Author keyword | 13 | 61% | 3% | 14 |
| 4 | FIBROLAMELLAR | Author keyword | 12 | 63% | 3% | 12 |
| 5 | COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA | Author keyword | 12 | 86% | 1% | 6 |
| 6 | COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA | Author keyword | 12 | 52% | 4% | 16 |
| 7 | SCIRRHOUS HEPATOCELLULAR CARCINOMA | Author keyword | 10 | 73% | 2% | 8 |
| 8 | COMBINED HEPATOCELLULAR AND CHOLANGIOCELLULAR CARCINOMA | Author keyword | 8 | 100% | 1% | 5 |
| 9 | FIBROLAMELLAR HEPATOCARCINOMA | Author keyword | 6 | 80% | 1% | 4 |
| 10 | FIBROLAMELLAR CARCINOMA OF THE LIVER | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHOLANGIOCELLULAR CARCINOMA | 4 | 14% | 6% | 28 |
| 2 | FIBROLAMELLAR | 3 | 100% | 1% | 3 |
| 3 | VITAMIN B12 BINDING CAPACITY | 3 | 100% | 1% | 3 |
| 4 | DOUBLE CANCER | 2 | 44% | 1% | 4 |
| 5 | HEPATIC CARCINOMA | 2 | 67% | 0% | 2 |
| 6 | CONVENTIONAL HEPATOCELLULAR CARCINOMA | 1 | 100% | 0% | 2 |
| 7 | COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA | 1 | 15% | 1% | 6 |
| 8 | PROGENITOR CELL ORIGIN | 1 | 27% | 1% | 3 |
| 9 | FIBROLAMELLAR CARCINOMA | 1 | 12% | 2% | 7 |
| 10 | COMBINED HEPATOCELLULAR CHOLANGIOCELLULAR CARCINOMA | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Review of the clinicopathologic features of fibrolamellar carcinoma | 2007 | 40 | 83 | 70% |
| Fibrolamellar Hepatocellular Carcinoma | 2009 | 33 | 84 | 68% |
| A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma | 2012 | 16 | 53 | 58% |
| Imaging Features of Fibrolamellar Hepatocellular Carcinoma | 2014 | 3 | 54 | 67% |
| Pathology of combined hepatocellular-cholangiocarcinoma | 2010 | 17 | 32 | 59% |
| Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors | 2011 | 20 | 75 | 44% |
| Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity | 2014 | 1 | 21 | 76% |
| Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature | 2007 | 4 | 11 | 91% |
| Combined Hepatocellular Cholangiocarcinoma: A Case Report and Review of Literature | 2013 | 1 | 26 | 77% |
| Management of combined hepatocellular and cholangiocarcinoma | 2008 | 30 | 78 | 32% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ABT GASTROENTEROL INFEKTIOL HEPATOL | 1 | 50% | 0.2% | 1 |
| 2 | ASP CATANIA 3 | 1 | 50% | 0.2% | 1 |
| 3 | GEN DIGEST TRANSPLANT SURG | 1 | 50% | 0.2% | 1 |
| 4 | HBP SURG TRANSPLANTAT UNIT | 1 | 50% | 0.2% | 1 |
| 5 | INVEST CANC THER EUT PHASE PROGRAM 1 | 1 | 50% | 0.2% | 1 |
| 6 | LIVER TRANSPLANT HEPATOL UNIT | 1 | 50% | 0.2% | 1 |
| 7 | MED XAVIER BICHAT INSERM U410 | 1 | 50% | 0.2% | 1 |
| 8 | NORTHWEST LIVER PROGRAM | 1 | 50% | 0.2% | 1 |
| 9 | UNIT HBP SURG LIVER TRANSPLANTAT IMIBIC | 1 | 50% | 0.2% | 1 |
| 10 | ABT INNERE MED GASTROENTEROL INFEKTIOL | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000195821 | HEP PAR 1//NEEDLE TRACK SEEDING//HEPPAR 1 |
| 2 | 0.0000188412 | PRIMARY HEPATIC CARCINOID TUMOR//PRIMARY HEPATIC NEUROENDOCRINE TUMOR//LIVER CARCINOID |
| 3 | 0.0000166855 | BILE DUCT TUMOR THROMBUS//INTRABILIARY GROWTH//BILE DUCT THROMBUS |
| 4 | 0.0000159661 | FOCAL NODULAR HYPERPLASIA//HEPATOCELLULAR ADENOMA//HEPATIC ADENOMA |
| 5 | 0.0000112881 | ADENOMATOUS HYPERPLASIA//MACROREGENERATIVE NODULES//LIVER CELL DYSPLASIA |
| 6 | 0.0000100651 | ANGIOTONIN//HOSP UNIV CASSIANO ANTONIO DE MORAIS//HYPERTENSIN |
| 7 | 0.0000096281 | BILIODIGESTIVE ANASTOMOSES//BERUFSGENOSSEN AFTL KLIN BERGMANNSHEIL//EARLY AND LATE RESULTS |
| 8 | 0.0000093033 | CHOLANGIOCARCINOMA//HILAR CHOLANGIOCARCINOMA//INTRAHEPATIC CHOLANGIOCARCINOMA |
| 9 | 0.0000086713 | HEPATOBLASTOMA//MESENCHYMAL HAMARTOMA//UNDIFFERENTIATED EMBRYONAL SARCOMA |
| 10 | 0.0000078009 | MILAN CRITERIA//UCSF CRITERIA//SALVAGE LIVER TRANSPLANTATION |